Detalhe da pesquisa
1.
NCI10066: a Phase 1/2 study of olaparib in combination with ramucirumab in previously treated metastatic gastric and gastroesophageal junction adenocarcinoma.
Br J Cancer
; 130(3): 476-482, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38135713
2.
Futibatinib, an Irreversible FGFR1-4 Inhibitor for the Treatment of FGFR-Aberrant Tumors.
Oncologist
; 28(11): 928-943, 2023 Nov 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37390492
3.
Safety and feasibility of initiating a hepatic artery infusion pump chemotherapy program for unresectable colorectal liver metastases: A multicenter, retrospective cohort study.
J Surg Oncol
; 123(1): 252-260, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33095919
4.
Mucosal Melanoma: Epidemiology, Biology and Treatment.
Cancer Treat Res
; 167: 295-320, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26601869
5.
Amplifying the Patient's Voice in Oncology Early-Phase Clinical Trials: Solutions to Burdens and Barriers.
Am Soc Clin Oncol Educ Book
; 44(3): e433648, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38857456
6.
Pembrolizumab Plus Binimetinib With or Without Chemotherapy for MSS/pMMR Metastatic Colorectal Cancer: Outcomes From KEYNOTE-651 Cohorts A, C, and E.
Clin Colorectal Cancer
; 23(2): 183-193, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38653648
7.
Pembrolizumab Plus mFOLFOX7 or FOLFIRI for Microsatellite Stable/Mismatch Repair-Proficient Metastatic Colorectal Cancer: KEYNOTE-651 Cohorts B and D.
Clin Colorectal Cancer
; 23(2): 118-127.e6, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38762348
8.
A Review of Advances in Radiotherapy in the Setting of Esophageal Cancers.
Surg Oncol Clin N Am
; 32(3): 433-459, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37182986
9.
Combination of Immunotherapy and Radiation Therapy in Gastrointestinal Cancers: An Appraisal of the Current Literature and Ongoing Research.
Curr Oncol
; 30(7): 6432-6446, 2023 07 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37504333
10.
A phase I trial of riluzole and sorafenib in patients with advanced solid tumors: CTEP #8850.
Oncotarget
; 14: 302-315, 2023 04 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37036756
11.
The Cholangiocarcinoma in the Young (CITY) Study: Tumor Biology, Treatment Patterns, and Survival Outcomes in Adolescent Young Adults With Cholangiocarcinoma.
JCO Precis Oncol
; 7: e2200594, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37561981
12.
Molecular profiling and treatment pattern differences between intrahepatic and extrahepatic cholangiocarcinoma.
J Natl Cancer Inst
; 115(7): 870-880, 2023 07 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37040087
13.
Importance of including patients with comorbidities in clinical trials.
Lancet Oncol
; 17(1): 17-8, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26758750
14.
Treating Biliary Tract Cancers: New Targets and Therapies.
Drugs
; 82(17): 1629-1647, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36441502
15.
Disease Control Achieved Using Atezolizumab + Bevacizumab in a Patient With Sarcomatoid Hepatocellular Carcinoma (SHCC), a Rare Variant Excluded From the IMbrave150 Trial.
J Investig Med High Impact Case Rep
; 10: 23247096221129470, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36541195
16.
A phase Ib dose-escalation study of troriluzole (BHV-4157), an oral glutamatergic signaling modulator, in combination with nivolumab in patients with advanced solid tumors.
Eur J Med Res
; 27(1): 107, 2022 Jul 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35780243
17.
First-in-human phase I/II, open-label study of the anti-OX40 agonist INCAGN01949 in patients with advanced solid tumors.
J Immunother Cancer
; 10(10)2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36316061
18.
Pembrolizumab for previously treated advanced anal squamous cell carcinoma: results from the non-randomised, multicohort, multicentre, phase 2 KEYNOTE-158 study.
Lancet Gastroenterol Hepatol
; 7(5): 446-454, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35114169
19.
Making National Cancer Institute-Designated Comprehensive Cancer Center Knowledge Accessible to Community Oncologists via an Online Tumor Board: Longitudinal Observational Study.
JMIR Cancer
; 8(2): e33859, 2022 05 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-35588361
20.
Immuno-oncologic care during COVID-19: Challenges and opportunities for improving clinical care and investigation.
J Cancer Biol
; 2(3): 75-82, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-35224563